• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病中的生活方式改变

Life-style modification in peripheral arterial disease.

作者信息

Khan S, Cleanthis M, Smout J, Flather M, Stansby G

机构信息

Northern Vascular Unit, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.

出版信息

Eur J Vasc Endovasc Surg. 2005 Jan;29(1):2-9. doi: 10.1016/j.ejvs.2004.09.020.

DOI:10.1016/j.ejvs.2004.09.020
PMID:15570264
Abstract

OBJECTIVE

To review the published evidence supporting the use of life-style modification in peripheral arterial disease (PAD).

DESIGN

A systematic search of the medical literature was performed for relevant studies.

MATERIALS

The publications obtained were then searched for randomised clinical trials which reported end-points of mortality or major cardiovascular event rates with various life-style modifications.

RESULTS

Only one randomised controlled trial was found reporting relevant end-points. Other trials were of other end-points such as walking distance or biochemical markers.

CONCLUSIONS

There is a lack of randomised controlled data proving the benefit of life-style modification in improving mortality and reducing cardiovascular events in patients with PAD. Despite this there is sufficient evidence to recommend some life-style modification as part of the overall approach to risk reduction in these patients. There is compelling evidence to support smoking cessation, increased exercise and improved diet.

摘要

目的

回顾已发表的支持在外周动脉疾病(PAD)中采用生活方式改变的证据。

设计

对医学文献进行系统检索以查找相关研究。

材料

然后在获得的出版物中查找报告了各种生活方式改变的死亡率或主要心血管事件发生率等终点指标的随机临床试验。

结果

仅发现一项报告了相关终点指标的随机对照试验。其他试验的终点指标为步行距离或生化标志物等。

结论

缺乏随机对照数据来证明生活方式改变对改善PAD患者死亡率和降低心血管事件的益处。尽管如此,仍有充分证据推荐一些生活方式改变作为这些患者总体风险降低方法的一部分。有令人信服的证据支持戒烟、增加运动和改善饮食。

相似文献

1
Life-style modification in peripheral arterial disease.外周动脉疾病中的生活方式改变
Eur J Vasc Endovasc Surg. 2005 Jan;29(1):2-9. doi: 10.1016/j.ejvs.2004.09.020.
2
Comments regarding "a systematic review of implementation of established recommended secondary prevention measures in PAOD".
Eur J Vasc Endovasc Surg. 2010 Jan;39(1):87-8. doi: 10.1016/j.ejvs.2009.10.010. Epub 2009 Nov 10.
3
Medical treatment of peripheral arterial disease: a comprehensive review.外周动脉疾病的医学治疗:全面综述
J Vasc Interv Radiol. 2004 Nov;15(11):1197-207. doi: 10.1097/01.RVI.0000137978.15352.C6.
4
Peripheral arterial disease: a high risk - but neglected - disease population.外周动脉疾病:一个高风险但被忽视的疾病群体。
BMC Cardiovasc Disord. 2005 Jun 22;5(1):15. doi: 10.1186/1471-2261-5-15.
5
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.外周动脉疾病患者的最佳危险因素修正与药物治疗
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401.
6
Peripheral artery disease: therapeutic advances.外周动脉疾病:治疗进展
Expert Rev Cardiovasc Ther. 2008 Apr;6(4):539-53. doi: 10.1586/14779072.6.4.539.
7
The role of exercise training in peripheral arterial disease.运动训练在外周动脉疾病中的作用。
Vasc Med. 2007 Nov;12(4):351-8. doi: 10.1177/1358863X07083177.
8
The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence.在地中海地区冠心病发病率较低的人群中,外周动脉闭塞性疾病与主要冠状动脉事件的关联。
Eur J Vasc Endovasc Surg. 2008 Jul;36(1):71-6. doi: 10.1016/j.ejvs.2008.01.029. Epub 2008 Apr 18.
9
Medical treatment of peripheral arterial disease.外周动脉疾病的医学治疗。
JAMA. 2006 Feb 1;295(5):547-53. doi: 10.1001/jama.295.5.547.
10
Peripheral arterial disease: a review of disease awareness and management.外周动脉疾病:疾病认知与管理综述
Am J Geriatr Pharmacother. 2006 Dec;4(4):365-79. doi: 10.1016/j.amjopharm.2006.12.006.

引用本文的文献

1
Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation.当前下肢外周动脉疾病的医学治疗和血运重建:对亚临床慢性炎症的影响。
Int J Mol Sci. 2023 Nov 8;24(22):16099. doi: 10.3390/ijms242216099.
2
Cilostazol for intermittent claudication.西洛他唑治疗间歇性跛行。
Cochrane Database Syst Rev. 2021 Jun 30;6(6):CD003748. doi: 10.1002/14651858.CD003748.pub5.
3
Increased cold injuries and the effect of body mass index in patients with peripheral vascular disease.
周围血管疾病患者中寒冷损伤增加及体重指数的影响
BMC Public Health. 2021 Feb 5;21(1):294. doi: 10.1186/s12889-020-09789-w.
4
Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database.西洛他唑在周围动脉疾病中的安全性:来自初级医疗保健电子数据库的队列研究
BMC Cardiovasc Disord. 2018 May 8;18(1):85. doi: 10.1186/s12872-018-0822-4.
5
Cilostazol for intermittent claudication.西洛他唑用于间歇性跛行。
Cochrane Database Syst Rev. 2014 Oct 31;2014(10):CD003748. doi: 10.1002/14651858.CD003748.pub4.
6
Increasing walking in patients with intermittent claudication: protocol for a randomised controlled trial.增加间歇性跛行患者的步行量:一项随机对照试验的方案。
BMC Cardiovasc Disord. 2010 Oct 7;10:49. doi: 10.1186/1471-2261-10-49.
7
Statin-associated muscle-related adverse effects: a case series of 354 patients.他汀类药物相关肌肉相关不良反应:354 例患者的病例系列。
Pharmacotherapy. 2010 Jun;30(6):541-53. doi: 10.1592/phco.30.6.541.
8
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.国际抗动脉粥样血栓形成持续健康注册研究的 3 年随访和事件发生率。
Eur Heart J. 2009 Oct;30(19):2318-26. doi: 10.1093/eurheartj/ehp355. Epub 2009 Aug 31.
9
Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities.下肢外周动脉疾病首次入院后的长期生存情况。
BMC Cardiovasc Disord. 2009 Aug 28;9:43. doi: 10.1186/1471-2261-9-43.